Research in Social and Administrative Pharmacy
Volume 1, Issue 2 , Pages 135-138 , June 2005

The interaction of direct-to-consumer prescription drug advertising and stakeholders in the medication use process

  • Shane P. Desselle, Ph.D. (Editor-in-Chief)

      Affiliations

    • Corresponding Author InformationCorresponding author: Shane P. Desselle, Ph.D., Office of Assessment and Educational Strategies, Associate Professor of Pharmacy Administration, Mylan School of Pharmacy, Duquesne University, Bayer Learning Center, Pittsburgh, PA 15282.

References 

  1. Rosenthal MB, Berndt ER, Donohue JM, Frank RG, Epstein AM. Promotion of prescription drugs to consumers. N Engl J Med. 2002;346:498–505
  2. Kemper DW, Mettler M. A consumer-empowered response to direct-to-consumer advertising of prescription drugs. Manag Care Q. 2002;10:52–54
  3. Bradley LR, Zito JM. Direct-to-consumer prescription drug advertising. Med Care. 1997;35:86–92
  4. Lipsky MS, Taylor CA. The opinions and experiences of family physicians regarding direct-to-consumer advertising. J Fam Pract. 1997;45:495–499
  5. Levy S. What do consumers really think about DTC Rx Ads? Available at http://www.DrugTopics.com. Accessed on March 19, 1999.
  6. Pinto MB. On the nature and properties of appeals used in direct-to-consumer advertising of prescription drugs. Psychol Rep. 2000;86:597–607
  7. Woloshin S, Schwartz LM, Tremmel J, Welch HG. Direct-to-consumer advertisements for prescription drugs: what are Americans being sold?. Lancet. 2000;358:1141–1146
  8. Holmes ER, Desselle SP. Evaluating the balance of informative and persuasive content within product-specific print DTCs ads. Drug Inf J. 2004;38:83–98
  9. Zachry WM, Shepherd MD, Hinich MJ, et al. Relationship between direct-to-consumer advertising and physician diagnosing and prescribing. Am J Health Syst Pharm. 2002;59:42–49
  10. Glinert LH. TV commercials for prescription drugs: a discourse analytic perspective. Res Soc Adm Pharm. 2005;1:158–184
  11. Glinert LH, Schommer JC. Television advertisement format and the provision of risk information about prescription drug products. Res Soc Adm Pharm. 2005;1:185–210
  12. Sewak S, Wilkin N, Bentley J, Smith M. Direct-to-consumer advertising via the Internet: the role of Web site design. Res Soc Adm Pharm. 2005;1:289–309
  13. Liu Y, Doucette WR, Farris KB, Nayakankuppam D. Drug information-seeking intention and behavior after exposure to direct-to-consumer advertisements of prescription drugs. Res Soc Adm Pharm. 2005;1:251–269
  14. Young HN, Lipwoski EE, Cline RJW. Using social cognitive theory to explain consumers' behavioral intentions in response to direct-to-consumer prescription drug advertising. Res Soc Adm Pharm. 2005;1:270–288
  15. Hansen RA, Schommer JC, Cline RR, Hadsall RS, Schondelmeyer SW, Nyman JA. The association of consumer cost-sharing and direct-to-consumer advertising with prescription drug use. Res Soc Adm Pharm. 2005;1:139–157
  16. Schommer JC, Singh RL, Hansen RA. Distinguishing characteristics of patients who seek more information or request a prescription in response to direct-to-consumer advertisements. Res Soc Adm Pharm. 2005;1:231–250
  17. Shah MB, Bentley JP, McCaffrey DJ, Kolassa EM. Direct-to-consumer advertisements and the patient-physician relationship. Res Soc Adm Pharm. 2005;1:211–230
  18. Hansen RA, Droedge M. Methodological challenges surrounding direct-to-consumer advertising research: the measurement conundrum. Res Soc Adm Pharm. 2005;1:331–347
  19. Schommer JC, Hansen RA. The study of direct-to-consumer advertising of prescription drugs. Res Soc Adm Pharm. 2005;1:348–368
  20. Mintzes B, Barer M, Lexchin J, Bassett KL. Introduction of direct-to-consumer advertising of prescription drugs in Canada: an opinion survey on regulatory policy. Res Soc Adm Pharm. 2005;1:310–330

PII: S1551-7411(05)00033-1

doi: 10.1016/j.sapharm.2005.03.001

Research in Social and Administrative Pharmacy
Volume 1, Issue 2 , Pages 135-138 , June 2005

Article Tools